Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 12:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1584 of 5,313 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Individual Therapy Clear all

Conditions: Non-Muscle Invasive Bladder Cancer
Interventions: Nadofaragene Firadenovec, Gemcitabine, Docetaxel; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 9
States / cities: Baltimore, Maryland • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Conditions: Von Willebrand Diseases
Interventions: Not listed
Lead sponsor: American Thrombosis and Hemostasis Network; Network
Eligibility: Not listed
Enrollment: 108 participants
Timeline: 2019 – 2026
U.S. locations: 22
States / cities: Orange, California • Aurora, Colorado • Farmington, Connecticut + 19 more

Conditions: Cystic Fibrosis (CF), Achromobacter Infection
Interventions: AchromoPhage; Biological
Lead sponsor: Ghady Haidar; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Dermatitis, Atopic
Interventions: Combination therapy GSK2894512 Cream A + GSK2894512 Cream B, Combination therapy Vehicle Cream A + Vehicle Cream B; Drug
Lead sponsor: Stiefel, a GSK Company; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: laparoscopic Roux-en-Y gastric bypass (RYGB) procedure, Lifestyle Intervention; Procedure · Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 25 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Seattle, Washington

Conditions: Substance Use Disorders
Interventions: Critical Time Intervention-Residential (CTI-R), Enhanced Usual Discharge Services-Residential; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Dementia, Cognitive Impairment
Interventions: LifeBio Memory; Other
Lead sponsor: Benjamin Rose Institute on Aging; Other
Eligibility: 18 Years to 112 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Gene Therapy, Hemophilia B
Interventions: Interview; Behavioral
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 12 Years and older
Enrollment: 150 participants
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pancreas Cancer, Lung Cancer, Renal Cancer, Adrenal Metastases, Prostate Cancer, Liver Metastases, Oligoprogressive Nodal Metastases, Metachronous Nodal Metastases, Synchronous Nodal Metastases, Mesothelioma, Spine Metastases, Brain Metastases, Borderline Resectable Pancreatic Carcinoma
Interventions: MR-guided Linac; Radiation
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Motivation
Interventions: Direct tDCS, Indirect tDCS, Personalized tDCS, Sham tDCS; Device
Lead sponsor: Northeastern University; Other
Eligibility: 65 Years to 80 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Recent-Onset Psychosis, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Psychotic Features, Major Depression With Psychotic Features, Psychotic Disorder Not Otherwise Specified (NOS)
Interventions: Multifamily Group Psychoeducation (MFG), Cognitive Remediation (CR); Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 35 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Overweight and Obesity
Interventions: FOCUS; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 7 Years to 11 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Multiple Sclerosis
Interventions: Neuromodulation Rehabilitation; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Autism Spectrum Disorder (ASD)
Interventions: Launching! to adulthood group therapy, standard of care; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Human Immunodeficiency Virus
Interventions: Anti-Retroviral Treatment and Access to Services (ARTAS); Other
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 1,893 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Hartford, Connecticut • Boston, Massachusetts • Philadelphia, Pennsylvania

Conditions: Alzheimer Disease and Related Dementias
Interventions: Promoting Positive Care Interactions (PPCI), PPCI-Staff Education Only (EO); Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 65 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Graft vs Host Disease
Interventions: Pregnyl®; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 76 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Social Anxiety Disorder
Interventions: Interpretation Bias Modification, Progressive Muscle Relaxation; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Distress, Emotional, Depression, Anxiety, Fatigue, Pain, Insomnia
Interventions: Individualized Evidence-Based Therapy in Cancer (Patients and Caregivers), Training in Individualized Evidence-Based Therapy in Cancer (Therapists); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Emotion Regulation, Mood Disorders, Stress Disorder, Anxiety Disorders, OCD, Impulse Control Disorder, Eating Disorders, Emotional Dysfunction, Emotional Instability, Emotional Distress, Emotional Maladjustment, Emotional Impulsivity, Obsessive-Compulsive Disorder, Emotion Dysregulation, Borderline Personality Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), electrical scalp stimulation, Cognitive Restructuring, Emotional Awareness Training; Device · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stress, Resilience and Mental Health of First Responders, Work Engagement, Musculoskeletal Discomfort, First Responders
Interventions: Mindfulness in Motion for First Responders; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Smoking Cessation
Interventions: Spotlight on Smoke-Free Living: Mindsets and Decisions, Transdermal Nicotine Patch; Behavioral · Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Hypertension, Mild Cognitive Impairment
Interventions: Mindfulness and DASH Diet Education, Education group; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 65 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Neoplasms
Interventions: Veliparib + VX-970 + Cisplatin; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 3
States / cities: Bethesda, Maryland • Boston, Massachusetts • Houston, Texas

Search by objective public record fields.

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

ATHN 9: Severe VWD Natural History Study

Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection

A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream

Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes

Intervention for Persons Leaving Residential Substance Abuse Treatment

LifeBio Memory Digital Reminiscence Platform

Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy

Stereotactic Magnetic Resonance Guided Radiation Therapy

TDCS to Improve Motivation and Memory in Elderly (TIME)

Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

Familial Overweight: Comparing Use of Strategies

Exploring the Use of Non-invasive Neuromodulation Combined With Exercise in People With Advanced Multiple Sclerosis (MS)

A Trial of the Launching! to Adulthood Program

Cooperative Re-Engagement Controlled Trial (CoRECT)

Promoting Positive Care Interactions (PPCI) in Assisted Living

Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD

Computerized Treatment for Social Anxiety

Training in Evidence-based Treatments in Psycho-Oncology

Neurostimulation Versus Therapy for Problems With Emotions

Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders

Smoking Cessation Intervention

Brain Connections and Blood Pressure

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors